Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study. uri icon

authors

  • Nelson, T L
  • Kamineni, A
  • Psaty, B
  • Cushman, M
  • Jenny, N S
  • Hokanson, J
  • Furberg, C
  • Mukamal, K J

publication date

  • January 1, 2010